Dilated Cardiomyopathy
Population
Patients with nonischemic dilated cardiomyopathy (DCM) and their family members
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
May guide DCM evaluation and family screening; leaves open prospective validation of arrhythmia risk stratification.
Structured PICO
P
Population
Patients with nonischemic dilated cardiomyopathy (DCM) and their family members
I
Intervention
Comprehensive genetic testing and cascade genetic testing
Genetic evaluation in nonischemic dilated cardiomyopathy aids in refining disease subtypes, predicting prognosis (especially arrhythmia risk), and enabling early intervention through cascade testing in family members.
Cite This Study
McNally et al. (2017) studied this question.